Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Joint Pain Injections Market Revenue Growth On Track For A 12.3% CAGR Through 2030#_x000D_
The market size for joint pain injections has experienced rapid growth in recent years. It is projected to increase from $6.12 billion in 2025 to $6.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. The expansion observed in the historic period can be linked to the rising prevalence of arthritis and various joint disorders, an aging global population, the increasing demand for minimally invasive pain treatments, greater awareness of regenerative therapies, and the broadening scope of orthopedic specialty care._x000D_
_x000D_
The joint pain injections market size is projected to experience significant expansion in the coming years. This market is set to grow to $10.96 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. The projected growth during the forecast period is attributable to the increasing embrace of biologic pain therapies, a rising emphasis on personalized medicine, the broader scope of sports injury management, growing investments in regenerative medicine, and an increasing preference for non-opioid pain management. Notable trends for the forecast period include the increasing adoption of non-surgical pain management therapies, a rising use of hyaluronic acid and PRP injections, growing demand for personalized pain treatment approaches, the expansion of regenerative medicine-based injections, and an enhanced focus on outpatient pain relief solutions._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Joint Pain Injections Market Growth Backed By Core Demand Fundamentals#_x000D_
An increasing prevalence of arthritis and musculoskeletal disorders is set to propel the growth of the joint pain injections market. Musculoskeletal disorders stand as the largest cause of disability globally, with low back pain being the single most common source of impairment in 160 nations. Patients utilize injections for both pain relief and inflammatory conditions. For instance, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a U.S.-based independent health research organization, reported that by 2050, an estimated 1 billion people are projected to suffer from osteoarthritis. Therefore, the expanding incidence of arthritis and musculoskeletal disorder is a key driver for the joint pain injections market._x000D_
_x000D_
#Joint Pain Injections Market Segment Analysis And Revenue Potential#_x000D_
The joint pain injections market covered in this report is segmented – _x000D_
_x000D_
1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections_x000D_
2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types_x000D_
3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies_x000D_
_x000D_
Subsegments:_x000D_
1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections_x000D_
2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections_x000D_
_x000D_
#Joint Pain Injections Market Growth Trends Reshaping The Competitive Landscape#_x000D_
Leading companies in the joint pain injection sector are focusing on developing innovations such as single-injection formulations, which prioritize patient convenience. A single-injection formulation refers to a drug delivery system designed to administer a specific medication dose through one injection, providing sustained therapeutic effects over a prolonged period without the need for multiple doses. For instance, in July 2024, LG Chem Ltd., a South Korea-based chemicals company, introduced Synovian, a new treatment for knee osteoarthritis in China that offers a convenient single-injection formulation, making it the first of its kind in the country. The product aims to penetrate a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed using proprietary technology, it showcases innovation in addressing patient needs, with an emphasis on providing effective relief with minimal administration hassle._x000D_
_x000D_
#Joint Pain Injections Market Leading Companies And Competitive Benchmarking#_x000D_
Major companies operating in the joint pain injections market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus Inc., Flexion Therapeutics Inc., Ferring Pharmaceuticals Inc., Sanofi S.A., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited, AstraZeneca plc _x000D_
_x000D_
#View The Full Joint Pain Injections Market Report:#_x000D_
_x000D_
#Joint Pain Injections Market Largest Region By Revenue And Market Share#_x000D_
North America was the largest region in the joint pain injections market in 2025. The regions covered in the joint pain injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
